PAR 2.04% 24.0¢ paradigm biopharmaceuticals limited..

Double blinded trials can't be stopped early due to...

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    Double blinded trials can't be stopped early due to "overwhelming signs" of significance as the efficacy data is unknown until all have been through the treatment and then the data becomes known. Based on what ive seen before, it could be a legitimate pause (blame COVID), could be drug supply issues (another pause), pure lack of volunteers, or that the safety monitoring board have seen something in the blood work which warrants halting the trial. i don't think any scenario is a positive. If its just a legit pause, fine, but its still a negative. The IR in this co is absolutely woeful. Be very interesting come AGM time. PR is in for a rough day
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.005(2.04%)
Mkt cap ! $83.98M
Open High Low Value Volume
25.0¢ 25.5¢ 24.0¢ $202.2K 814.1K

Buyers (Bids)

No. Vol. Price($)
5 181098 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 118621 5
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.